Investigating how brain blood vessels contribute to inflammation in Alzheimer's Disease

Cerebrovascular mitochondria as mediators of neuroinflammation in Alzheimer's Disease

NIH-funded research Temple Univ of the Commonwealth · NIH-10895539

This study is looking at how certain parts of brain cells might be affected by a sticky protein linked to Alzheimer's, and how this could lead to inflammation in the brain; the goal is to find new ways to help improve treatments for people with Alzheimer's.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionTemple Univ of the Commonwealth NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-10895539 on NIH RePORTER

What this research studies

This research focuses on understanding the role of cerebrovascular mitochondria in the development of neuroinflammation associated with Alzheimer's Disease (AD). It examines how the accumulation of amyloid beta around brain blood vessels can lead to dysfunction in the neurovascular unit, which is crucial for maintaining brain health. By studying the mechanisms of amyloid clearance and the impact of mitochondrial function in endothelial cells, the research aims to uncover new insights into the progression of AD and potential therapeutic targets. Patients may benefit from findings that could lead to improved treatments for managing or preventing neuroinflammation in Alzheimer's.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's Disease or those exhibiting early signs of cognitive decline.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's Disease may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating neuroinflammation in Alzheimer's Disease, potentially slowing disease progression.

How similar studies have performed: Previous research has shown promising results in understanding the role of amyloid beta in neuroinflammation, making this approach a continuation of established findings.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.